Crowdonomics
All companies
Zoi logo

Zoi

Operating

Zoi, Inc.

Healthcare · Los Angeles, CA

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$63,039
Across 2 rounds since 2017
Latest share price
$0.21
Reg CF · Common Stock · Nov 2017 offering price

Financials

FY2014–FY2016 · from SEC filings · hover any figure for its source
$0
2014
$0
2015
$0
2016
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2014 unaudited*
FY2015 unaudited*
FY2016 unaudited*
Income statement
Revenue
$0
$0
$0
Cost of goods sold
$0
$0
$0
Net income
$0
$0
$0
Taxes paid
$0
$0
$0
Balance sheet
Cash
$0
$0
$0
Accounts receivable
$0
$0
$0
Total assets
$0
$0
$0
Short-term debt
$0
$0
$0
Long-term debt
$0
$0
$0
Total liabilities
$0
$0
$0
Other
Headcount
—
3
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Share price over rounds

$0.21$0.105$0.21
Mar 2017Nov 2017
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Fundraising history

Raised $11.4K / $55.3KInvestors 17
Raised $51.7K / $100KInvestors 93

Team

4 people
Bryan LordenFounder
CEO

Spent 7 years in the Navy as a Master At Arms. Bryan worked in food and beverage for 8 years as Sales manager. He spent the last 4 years leading startups which include slashmyfees.com and Zoi, Inc. and is currently a Regional Sales manager for Rembrandt Foods. He has been in the development stage with Zoi over the last 9 months.

Christian BroceFounder
CTO

Over 10 years experience in business development, contract writing and water treatment engineering. As an entrepreneur, started producing websites in 2006, and has launches several web applications and mobile apps for companies. In these companies he has lead roles of hands on technology development, information architecture, business management and development. As a day job, currently Christian is RME for a construction firm, performing business development in wastewater treatment industry specifically developing systems.

Boris Gansevich
Chief Innovation Officer

Boris has been involved with sleep medicine for over 10 years, holding various roles, from polysomnography technician to eventually owning his own diagnostic sleep business. For the past five years, Boris has been involved in system integration and mobile app building projects within the healthcare industry. Boris will help visualize and incorporate ideas for future development of Zoi platform.

Dr. Rico Simonini
Advisor

Dr. Simonini is a top cardiologist at Cedars Sinai Medical Center in Beverly Hills. He's provided Zoi with advice on how to track a users heart rate and sleep patterns.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 10 annual reports (FY2016–FY2025)

Missing: 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025

93 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-UApr 17, 20180001665160-18-000289
    EDGAR
  • Form C/AFeb 14, 20180001665160-18-000109
    EDGAR
  • Form C-UNov 16, 20170001665160-17-000587
    EDGAR
  • Form CNov 16, 20170001665160-17-000592
    EDGAR
  • Form C-UNov 16, 20170001665160-17-000586
    EDGAR
  • Form C-UJul 17, 20170001665160-17-000273
    EDGAR
  • Form C-UJul 17, 20170001665160-17-000274
    EDGAR
  • Form C/AJul 12, 20170001665160-17-000266
    EDGAR
Source: SEC EDGARCIK 0001701370DEShare price $0.21Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.